{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:08:59Z","timestamp":1791950939176,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.leukres.2023.107316","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T10:57:39Z","timestamp":1684580259000},"page":"107316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparison of a modified pediatric protocol versus a hyper-CVAD protocol in adolescents and young adults with Philadelphia-negative acute lymphoblastic leukemia: A multicenter retrospective analysis"],"prefix":"10.1016","volume":"130","author":[{"given":"Hind","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Eldadah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Alhejazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luluh","family":"Bin Dayil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-0247","authenticated-orcid":false,"given":"Ayman","family":"Almozaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roaa Reda","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej Al","family":"Mugairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Snnallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussab","family":"Damlaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alsaeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Mosa","family":"Bakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alahmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-8302","authenticated-orcid":false,"given":"Ihab","family":"Elhemaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Alamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Rajkhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solaf Sami","family":"Kanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah S. Al","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman Al","family":"Raizah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Absi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.leukres.2023.107316_bib1","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2008-06-164863","article-title":"Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century","volume":"113","author":"Pulte","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2023.107316_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/bjh.17268","article-title":"Outcomes in adolescent and young adult acute lymphoblastic leukaemia: a report from the Indian Acute Leukaemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)","volume":"193","author":"Ganesan","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"9881","key":"10.1016\/j.leukres.2023.107316_bib3","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.leukres.2023.107316_bib4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2008-01-130237","article-title":"What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies","volume":"112","author":"Stock","year":"2008","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.leukres.2023.107316_bib5","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403 [published correction appears in Blood","volume":"133","author":"Stock","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib6","first-page":"526","article-title":"Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic","volume":"29","author":"DeAngelo","year":"2015","journal-title":"Leuk Leuk"},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib7","first-page":"606","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic","volume":"32","author":"Toft","year":"2018","journal-title":"Leuk Leuk"},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pbc.20749","article-title":"Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII\/E2993) trials","volume":"48","author":"Ramanujachar","year":"2007","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.leukres.2023.107316_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/hematology.2019000009","article-title":"Pediatric-inspired protocols in adult acute lymphoblastic leukemia: are the results bearing fruit?","volume":"2019","author":"Muffly","year":"2019","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"10","key":"10.1016\/j.leukres.2023.107316_bib10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ajh.25229","article-title":"Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens","volume":"93","author":"Siegel","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.leukres.2023.107316_bib11","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"101","author":"Kantarjian","year":"2004","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.leukres.2023.107316_bib12","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1182\/blood.V114.22.3084.3084","article-title":"Outcome for adolescents and young adults (AYA) with the hyper-CVAD (with or without rituximab) regimens for de Novo Acute Lymphoblastic Leukemia (ALL) or lymphoblastic lymphoma","volume":"114","author":"Thomas","year":"2009","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.leukres.2023.107316_bib13","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1002\/cncr.28930","article-title":"Augmented Berlin-Frankfurt-M\u00fcnster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL)","volume":"120","author":"Rytting","year":"2014","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2023.107316_bib14","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2023.107316_bib15","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-10-116186","article-title":"Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study","volume":"111","author":"Pullarkat","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2023.107316_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.leukres.2023.107316_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study [published correction appears in J Clin Oncol. 2009 May 20;27(15):2574. Dosage error in article text]","volume":"27","author":"Huguet","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2023.107316_bib18","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/leu.2011.84","article-title":"Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis","volume":"25","author":"Teuffel","year":"2011","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/10428194.2017.1349902","article-title":"PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia \u2020","volume":"59","author":"Rausch","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.leukres.2023.107316_bib20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/10428194.2016.1218004","article-title":"Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection - a review","volume":"58","author":"Beaupin","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.leukres.2023.107316_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.25489","article-title":"L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase","volume":"117","author":"Pieters","year":"2011","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.leukres.2023.107316_bib22","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.2015.62.4544","article-title":"Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from children's oncology group study AALL0232","volume":"34","author":"Larsen","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.leukres.2023.107316_bib23","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1200\/JCO.2009.26.9456","article-title":"Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia","volume":"28","author":"Thomas","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.leukres.2023.107316_bib24","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1182\/blood-2008-06-164129","article-title":"CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy","volume":"112","author":"Dworzak","year":"2008","journal-title":"Blood"},{"issue":"9018","key":"10.1016\/j.leukres.2023.107316_bib25","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(96)91615-3","article-title":"Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children","volume":"347","year":"1996","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.leukres.2023.107316_bib26","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1080\/10428194.2020.1780583","article-title":"Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia","volume":"61","author":"G\u00f6kbuget","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2023.107316_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17474086.2017.1262757","article-title":"Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma","volume":"10","author":"Kadia","year":"2017","journal-title":"Expert Rev. Hematol."},{"issue":"12","key":"10.1016\/j.leukres.2023.107316_bib28","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/ajh.25957","article-title":"Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed\/refractory T-cell acute lymphoblastic leukemia\/lymphoma. A CAMPUS ALL study","volume":"95","author":"Candoni","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2023.107316_bib29","first-page":"95","article-title":"Hepatotoxicity secondary to chemotherapy","volume":"2","author":"Grigorian","year":"2014","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3892\/br.2017.851","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"6","author":"Zhang","year":"2017","journal-title":"Biomed. Rep."},{"issue":"4","key":"10.1016\/j.leukres.2023.107316_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood-2018-02-778530","article-title":"Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?","volume":"132","author":"Boissel","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.leukres.2023.107316_bib32","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ajh.24419","article-title":"Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-M\u00fcnster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen","volume":"91","author":"Rytting","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clml.2016.11.002","article-title":"Hyper-CVAD compared with BFM-like chemotherapy for the treatment of adult acute lymphoblastic Leukemia. A retrospective single-center analysis","volume":"17","author":"El-Cheikh","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"5","key":"10.1016\/j.leukres.2023.107316_bib34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/bloodadvances.2020003526","article-title":"Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol","volume":"5","author":"Rajendra","year":"2021","journal-title":"Blood Adv."},{"issue":"24","key":"10.1016\/j.leukres.2023.107316_bib35","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","article-title":"Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia","volume":"123","author":"Beldjord","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2023.107316_bib36","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","article-title":"Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies","volume":"120","author":"G\u00f6kbuget","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2023.107316_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.0580","article-title":"Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic Leukemia: a meta-analysis","volume":"3","author":"Berry","year":"2017","journal-title":"JAMA Oncol."},{"issue":"26","key":"10.1016\/j.leukres.2023.107316_bib38","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2015-03-580027","article-title":"Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies","volume":"125","author":"van Dongen","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.beha.2017.07.005","article-title":"Which patients should I transplant with acute lymphoblastic leukemia?","volume":"30","author":"Inbar","year":"2017","journal-title":"Best. Pr. Res Clin. Haematol."},{"issue":"2","key":"10.1016\/j.leukres.2023.107316_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.25338","article-title":"Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: a consensus of North American experts","volume":"94","author":"Short","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2023.107316_bib41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.leukres.2017.06.010","article-title":"The Dana Farber consortium protocol (DFCP) vs. classic Hyper-CVAD for treatment of acute lymphoblastic leukemia in patients <50 Y. Single institution experience","volume":"60","author":"Alabdulwahab","year":"2017","journal-title":"Leuk. Res"},{"issue":"1","key":"10.1016\/j.leukres.2023.107316_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2009.07712.x","article-title":"Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen","volume":"146","author":"Storring","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.leukres.2023.107316_bib43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.clml.2020.05.012","article-title":"Role of allogeneic HCT as postremission therapy for transplant-eligible adult lymphoblastic leukemia\/lymphoma after frontline hyper-CVAD","volume":"20","author":"Damlaj","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"5","key":"10.1016\/j.leukres.2023.107316_bib44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.23149","article-title":"Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis","volume":"87","author":"Ram","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"26","key":"10.1016\/j.leukres.2023.107316_bib45","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1182\/blood-2013-03-484592","article-title":"Young adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen do not need a bone marrow transplant in first remission","volume":"121","author":"Isakoff","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ajh.24285","article-title":"Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission","volume":"91","author":"Seftel","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2023.107316_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/jayao.2016.0060","article-title":"Graft-versus-host disease in adolescents and young adults (15-24 Years Old) after allogeneic hematopoietic stem cell transplantation for acute leukemia in first complete remission","volume":"6","author":"Vignon","year":"2017","journal-title":"J. Adolesc. Young Adult Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2023.107316_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bjh.13847","article-title":"Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003","volume":"172","author":"Hough","year":"2016","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623005817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212623005817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:04:13Z","timestamp":1758935053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212623005817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":48,"alternative-id":["S0145212623005817"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107316","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of a modified pediatric protocol versus a hyper-CVAD protocol in adolescents and young adults with Philadelphia-negative acute lymphoblastic leukemia: A multicenter retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2023.107316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107316"}}